Genitourinary Radiology

Deep learning plus CT imaging can assess incidental kidney masses

By Kate Madden Yee

Deep-learning models can noninvasively predict the likelihood of malignant and aggressive pathology of incidentally discovered renal masses based on preoperative CT images.

February 7, 2025

Use of PCCT with gadoxetate disodium shows promise for liver imaging

By Kate Madden Yee

Using photon-counting CT (PCCT) with the gadolinium-based contrast agent gadoxetate disodium shows promise for improved liver visualization at a lower dose than is required for CT exams using other GBCA agents.

February 6, 2025

Volume of AI-segmented lesions predicts prostate cancer outcomes

By Kate Madden Yee

An AI method for measuring prostate tumor volume based on multiparametric MRI (mpMRI) data shows promise for predicting treatment outcomes.

October 30, 2024

Dedicated ultrasound, MRI protocols improve endometriosis diagnosis

By Kate Madden Yee

Dedicated ultrasound and MRI protocols -- in contrast to routine ones -- are more effective in diagnosing endometriosis, researchers have reported.

September 13, 2024

AI model comparable to radiologists for finding prostate cancer on MRI

By Kate Madden Yee

A deep-learning model performs comparably to an abdominal radiologist when it comes to finding clinically significant prostate cancer on MRI, researchers have reported.

August 6, 2024

PCCT diagnoses kidney stones with 44% less radiation

By Kate Madden Yee

Using PCCT for abdominal imaging to diagnose kidney stones reduces patients' radiation exposure by 44% compared with conventional CT.

July 30, 2024

MRI-guided targeted biopsy shines for detecting aggressive prostate cancer

By Erik L. Ridley

Multiparametric MRI-guided targeted biopsy outperformed systematic biopsy for detecting two aggressive prostate cancer subtypes.

July 16, 2024

Ablation most cost-effective treatment for hepatocellular carcinoma

By Kate Madden Yee

Ablation is the most cost-effective treatment for hepatocellular carcinoma, researchers have found.

June 21, 2024

Can MRI replace the PSA test in prostate cancer screening?

By Kate Madden Yee

MRI isn't yet ready to replace prostate-specific antigen (PSA) testing as a first-line screening exam for prostate cancer, a new study has found.

June 3, 2024

PSMA-PET/CT effective in patients with kidney cancer

By Will Morton

PSMA-PET/CT has the potential to be an effective alternative imaging approach for diagnosing patients with renal cell carcinoma.

May 23, 2024

Blue Earth, Siemens ink deal for Posluma clinical trial

By AuntMinnie.com staff writers

The agreement enables Siemens to enhance its analytics and AI-based algorithms for prostate cancer image quantification and interpretation.

May 9, 2024

ARRS: How to manage the side effects of radiopharmaceuticals

By Liz Carey

Three clinical issues that may arise with theranostics treatments will require special provisions, according to a talk at ARRS 2024.

May 8, 2024

Page 1 of 91

Next Page